Mebhydrolin napadisylate CAS No.6153-33-9

Pharmaceutical Materials 2025-03-20

CAS No.6153-33-9

Name

mebhydroline 1.5-naphthalenedisulfonate

Synonyms

incidal

DIAZOLINE

mebhydrolin napadisilate

Mebhydrolin napadisylate

MEBHYDROLIN NAPADISYLATE

Mebhydroline napadisylate

MEBHYDROLINE NAPADISYLATE

MEBHYDROLINE 1.5-NAPHTHALENEDISULFONATE

mebhydroline 1.5-naphthalenedisulfonate

MEBHYDROLINE 1.5-NAPHTHALENEDISULFONATE SALT

9-Benzyl-N-Methyl-1.2.3.4-Tetrahydro-A-Carboline

Attribute Description
Chemical Name Mebhydrolin napadisylate
CAS Number N/A (specific CAS number for this salt may not be publicly available)
Formula C28H36N2O10S2 (general formula, may vary depending on specific salt formation)
Molecular Weight Approx. 604.76 g/mol (calculated based on general formula)
Synonyms Mebhydrolin disodium napadisylate, Mebhydrolin 1.1′-[1.4-butanediylbis(oxy)]bis[2-(3.5-dinitrobenzoyloxy)propane], etc.
Appearance Yellowish crystalline powder or solid
Solubility Soluble in water and organic solvents
Melting Point N/A (melting point may vary depending on the purity and crystalline form)
Pharmacological Action Mebhydrolin, the active ingredient, is a muscle relaxant used to treat muscle spasms and pain. The napadisylate salt form may enhance its solubility and bioavailability.
Indications Used in the treatment of muscle spasms, spasticity, and associated pain conditions.
Administration Administered orally or as directed by a healthcare professional.
Precautions Should be used with caution in patients with renal or hepatic impairment. Pregnant and breastfeeding women should consult a physician before use. Monitor for adverse reactions such as dizziness, drowsiness, and gastrointestinal disturbances.

Disclaimer: The above content is for reference and communication only among industry insiders, and does not guarantee its accuracy or completeness. According to relevant laws and regulations and the regulations of this website, units or individuals who purchase related items should obtain valid qualifications and qualification conditions.